Cross Shawn's Form 4 filing
Pacira BioSciences, Inc. (PCRX) · filed Apr 24, 2026
- Accession no.
- 0001628280-26-027287
- Filed
- Apr 24, 2026
- Trade date
- Apr 23, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $325.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cross ShawnCIK 0001734779 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common Stock | MOption exerciseAcquired | +12,941 | $16.45 | +$212,879.45 | 118,282 | Direct | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −12,941 | $25.16 | −$325,595.56 | 105,341 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common Stock | MOption exerciseDisposed | −12,941 | $0.00 | $0 | 150,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.